Advanced search
Publication Cover
Hematology Volume 12, 2007 - Issue 5
Submit an article Journal homepage
122
Views
15
CrossRef citations to date
0
Altmetric
Articles

Therapeutic evaluation and prognostic value of interim hybrid PET/CT with 18F-FDG after three to four cycles of chemotherapy in non-Hodgkin's lymphoma

Jinhua ZhaoDepartment of Nuclear MedicineThe First People's Hospital, Shanghai Jiaotong University, Shanghai200080, People's Republic of China
,
Wenli QiaoDepartment of Nuclear MedicineThe First People's Hospital, Shanghai Jiaotong University, Shanghai200080, People's Republic of China
,
Chun WangDepartment of HematologyThe First People's Hospital, Shanghai Jiaotong University, Shanghai200080, People's Republic of China
,
Taisong WangDepartment of Nuclear MedicineThe First People's Hospital, Shanghai Jiaotong University, Shanghai200080, People's Republic of China
&
Yan XingDepartment of Nuclear MedicineThe First People's Hospital, Shanghai Jiaotong University, Shanghai200080, People's Republic of China
Pages 423-430 | Published online: 04 Sep 2013

References

  • Canellos GP. CHOP may have been part of the beginning but certainly not the end: Issues in risk-related therapy of large-cell lymphoma. J Clin Oncol 1997;15:1713–1716.
  • Vose JM. Current approaches to the management of non-Hodgkin's lymphoma. Semin Oncol 1998;25:483–491.
  • The International non-Hodgkin's lymphoma prognostic factors project. A Predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993;329:987–994.
  • Mikhaeel NG, Hutchings M, Fields PA, O'Doherty MJ, Timothy AR. FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma. Ann Oncol 2005;16: 1514–1523.
  • Spaepen K, Stroobants S, Dupont P, Vandenberghe P, Thomas J, de Groot T, et al. Early restaging positron emission tomography with (18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma. Ann Oncol 2002;13: 1356–1363.
  • Jerusalem G, Beguin Y, Fassotte MF, Najjar F, Paulus P, Rigo P, et al. Persistent tumor 18F-FDG uptake after a few cycles of polychemotherapy is predictive of treatment failure in non-Hodgkin's lymphoma. Haematologica 2000;85:613–618.
  • Mikhaeel NG, Timothy AR, O'Doherty MJ, Hain S, Maisey MN. 18-FDG-PET as a prognostic indicator in the treatment of aggressive non-Hodgkin's lymphoma—comparison with CT. Leuk Lymphoma 2000;39: 543–553.
  • Torizuka T, Nakamura F, Kanno T, Futatsubashi M, Yoshikawa E, Okada H, et al. Early therapy monitoring with FDG-PET in aggressive non-Hodgkin's lymphoma and Hodgkin's lymphoma. Eur J Nucl Med Mol Imaging 2004; 31:22–28.
  • Kostakoglu L, Coleman M, Leonard JP, Kuji I, Zoe H, Goldsmith SJ. PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease. J Nucl Med 2002;43:1018–1027.
  • Hoekstra OS, Ossenkoppele GJ, Golding R, van Lingen A, Visser GW, Teule GJ, et al. Early treatment response in malignant lymphoma, as determined by planar fluorine-18-fluorodeoxyglucose scintigraphy. J Nucl Med 1993;34: 1706–1710.
  • Jerusalem G, Hustinx R, Beguin Y, Fillet G. Evaluation of therapy for lymphoma. Semin Nucl Med 2005;35:186–196.
  • Canellos GP. Residual mass in lymphoma may not be residual disease. J Chin Oncol 1988;6:931–933.
  • Segall GM. FDG PET imaging in patients with lymphoma: A clinical perspective. J Nucl Med 2001;42:609–610.
  • Jerusalem G, Begiun Y, Fassotte MF, Belhocine T, Hustinx R, Rigo P, et al. Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin's disease. Ann Oncol 2003;14:123–130.
  • Elstrom R, Guan L, Baker G, Nakhoda K, Vergilio JA, Zhuang H, et al. Utility of FDG-PET scanning in lymphoma by WHO classification. Blood 2003;101:3875–3876.
  • Jerusalem G, Warland V, Najjar F, Paulus P, Fassotte MF, Fillet G, et al. Whole-body 18F-FDG PET for the evaluation of patients with Hodgkin's disease and non-Hodgkin's lym-phoma. Nucl Med Commun 1999;20:13–20.
  • Jerusalem G, Beguin Y, Najjar F, Hustinx R, Fassotte MF, Rigo P, et al. Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL). Ann Oncol 2001;12: 825–830.
  • Jerusalem G, Beguin Y. Positron emission tomography in non-Hodgkin's lymphoma (NHL): Relationship between tracer uptake and pathological findings, including preliminary experience in the staging of low-grade NHL. Chin Lymphoma 2002;3:56–61.
  • Tatsumi M, Kitayama H, Sugahara H, Tokita N, Nakamura H, Kanakura Y, et al. Whole-body hybrid PET with 18F-FDG in the staging of non-Hodgkin's lymphoma. J Nucl Med 2001;42: 601–608.
  • Romer W, Hanauske AR, Ziegler S, Thodtmann R, Weber W, Fuchs C, et al. Positron emission tomography in non-Hodgkin's lymphoma: Assessment of chemotherapy with fluorodeoxyglucose. Blood 1998;91:4464–4471.
  • Friedberg JW, Fischman A, Neuberg D, Kim H, Takvorian T, Ng AK, et al. FDG-PET is superior to gallium scintigraphy in staging and more sensitive in the follow-up of patients with de novo Hodgkin lymphoma: A blinded comparison. Leuk Lymphoma 2004;45:85–92.
  • Hutchings M, Mikhaeel NG, Fields PA, Nunan T, Timothy AR. Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma. Ann Oncol 2005;16:1160–1168.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.